Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-10-05

Clinical Trial Update: Bivalirudin Infusion for Ventricular Infarction Limitation [Phase 3]

View source ↗

Summary

Phase 3 trial update for bivalirudin infusion in acute myocardial infarction; study terminated with posted results in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bivalirudin (bivalirudin)

Snippet

Sponsor: The Medicines Company | Conditions: Acute Myocardial Infarction | Phase 3 | Status: TERMINATED | Results posted: 2018-10-05